Podcasts · Wall Street Wildlife Investing Podcast
Should You Buy Compass Pathways? The Magic Mushroom Stock No Analyst Will Touch $CMPS $RKLB $SHOP $PNG (E151)
· 1 h 05 min · Episode 151
Episode Should You Buy Compass Pathways? The Magic Mushroom Stock No Analyst Will Touch $CMPS $RKLB $SHOP $PNG (E151)
Krzysztof pitches Compass Pathways: both phase 3 trials of its pharmaceutical psilocybin are already positive, approval looks likely in early 2027, and the company holds 400-plus million in cash against about 40 million a quarter of burn, which by his math is ten quarters of runway. Stanford's Kevin Mak took a position, and Krzysztof walks through Mak's seven structural reasons the stock hasn't rerated. Luke explains gilt laddering as the cash sleeve of a portfolio, which turns into an argument about whether the US can grow its way out of $40 trillion of debt with the 30-year over 5%, and he names HSBC for fumbling his CyberArk payout nearly a year after Palo Alto closed the deal. Voting is open on the September community portfolio: Kraken Robotics, Rocket Lab and Shopify.
🍄 Should you buy $CMPS? The drug works, both phase 3 trials are positive, and the one grey area is whether insurers pay for a dose that needs six-plus hours of clinician supervision
🧠 Kevin Mak's seven reasons: a UK ADR no US index owns, thin institutions, career risk for any analyst who says "buy the magic mushroom stock", no valuation framework, M&A unpriced. A $2 billion company sitting at $15 resistance off a low of $2; Mak's number if you run it is about $45 a share
🗳️ September community portfolio: Kraken Robotics, $RKLB and $SHOP, voting is open at wallstreetwildlife.com
🚀 Luke's Rocket Lab average buy was $3-something; it got as high as $130 and is a $60-something stock now
🛍️ Paul thought $SHOP was overvalued until he opened his own storefront on it; Luke says Shopify got him across the line into early retirement
🧘 Beginner's mind: look at a stock you think you already know with fresh eyes
💷 Gilts in a minute: short-dated UK government bonds, refreshed every six months, as the cash you never leave idle
🇺🇸 The 30-year over 5% on $40 trillion of debt: growth has to beat the interest bill, which is why Krzysztof holds Bitcoin (and the crypto that is not a crypto that shall not be mentioned)
🏦 HSBC vs Trading 212 on the CyberArk acquisition: one converted in a day, one buried itself in bureaucracy and broken processes. Why you should have more than one broker once the numbers get big
💻 Luke is officially addicted to vibe coding
SOURCES:
Luke's Gilt webinar: https://youtu.be/HVVj0u1O6ms
Jared Isaacman (NASA): https://youtu.be/VTF6p0U98ek?si=DgSH8GOAA_MuM0jb
SEGMENTS:
00:00 Cold open
00:56 Jury Duty, the Amazon show: "a bit mid" or the kindest thing on TV?
06:03 Real jury duty, Bezos and Saylor on one panel, and AI judges
08:02 Luke is officially addicted to vibe coding
12:07 Livestream Monday, Patreon welcomes
14:21 A dark thought about capitalism: why are you investing, and what is enough?
19:13 What the community portfolio is, and why you should get involved
20:46 September pitches: Kraken Robotics $PNG, $RKLB and $SHOP, and beginner's mind
27:02 Fiscal.ai: fiscal.ai/wildlife, first week of Pro free, 15% off
28:03 Krzysztof already owns $RKLB, and the option that soured him
28:52 Isaacman at All-In: a moon base as the staging post to Mars
31:36 Paul's Shopify message: a merchant's beginner's mind
33:28 Should you buy $CMPS? The drug works, the cash runs ten quarters
40:31 Kevin Mak's seven structural reasons, the chart, and $45
44:25 Biotech corner: "I am a disco", Nektar, Relay, TransMedics
48:01 Cash doesn't have to sit idle: gilts and the gilt ladder
52:13 The 30-year over 5% on $40 trillion of debt: growth, Bitcoin, $ASST
57:59 Chainlink: the cryptocurrency that isn't a cryptocurrency
59:09 CyberArk deal: HSBC vs Trading 212, and why your broker matters
01:03:46 Wrap
Fiscal.AI is the Complete Stock Research Platform for fundamental investors. Get 15% off any premium plan with:
fiscal.ai/wildlife
Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.